Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.80
+0.14 (2.10%)
At close: Sep 26, 2025, 4:00 PM EDT
6.92
+0.12 (1.76%)
After-hours: Sep 26, 2025, 7:24 PM EDT
Wave Life Sciences Stock Forecast
Stock Price Forecast
According to 17 professional analysts, the 12-month price target for Wave Life Sciences stock ranges from a low of $10 to a high of $36. The average analyst price target of $19.94 forecasts a 193.24% increase in the stock price over the next year.
Price Target: $19.94 (+193.24%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 7 | 8 |
| Buy | 5 | 5 | 7 | 8 | 8 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 13 | 15 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +164.71% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +223.53% | Sep 3, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +179.41% | Aug 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +208.82% | Jul 31, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $24 | Buy | Initiates | $24 | +252.94% | Jul 28, 2025 |
Financial Forecast
Revenue This Year
48.01M
from 108.30M
Decreased by -55.67%
Revenue Next Year
51.30M
from 48.01M
Increased by 6.85%
EPS This Year
-1.17
from -0.70
EPS Next Year
-1.21
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 89.3M | 106.1M | |||
| Avg | 48.0M | 51.3M | |||
| Low | 17.5M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -17.6% | 120.9% | |||
| Avg | -55.7% | 6.9% | |||
| Low | -83.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.97 | -0.79 | |||
| Avg | -1.17 | -1.21 | |||
| Low | -1.39 | -1.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.